COVID-19 associated viral myocarditis: does it exist?
Vaishali Verma1, Sachin Sondhi2, Rajesh Sharma3
1Department of Cardiology, Indira Gandhi Government Medical College, Shimla. vaishalisikerwar@gmail.com.
Insights
Elevated troponin levels indicate myocardial injury in 7-28% of patients with COVID-19. This cardiac complication is linked to worse outcomes and higher mortality rates in severe acute respiratory syndrome coronavirus-2 infections.
Area of Science:
- Cardiology
- Infectious Diseases
- Virology
Background:
- Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, is a global pandemic.
- Respiratory symptoms are the primary manifestation, but cardiac involvement is increasingly recognized.
Abstract:
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), is a lethal pandemic that has claimed millions of lives worldwide. While respiratory involvement is the most common and most virulent manifestation of COVID-19, there is enough data to suggest that myocardial injury reflected through elevated troponin levels is seen in around 7-28% of patients and is related with increased morbidity and mortality.
More Related Videos
12:24Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse
Published on: June 20, 2014
08:52Author Spotlight: Developing a Translational Model for Atrial Fibrillation Research Across Species
Published on: November 21, 2023
Related Concept Videos
Myocarditis III: Medical Management
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis I: Introduction
Cardiomyopathy I: Introduction and Classification
Myocarditis IV: Nursing Management
Cardiomyopathy III: Hypertrophic Cardiomyopathy
